Home/Filings/4/A/0000908662-09-000338
4/A//SEC Filing

MEADE HARRY 4/A

Accession 0000908662-09-000338

CIK 0000904973other

Filed

Nov 12, 7:00 PM ET

Accepted

Nov 13, 4:52 PM ET

Size

7.6 KB

Accession

0000908662-09-000338

Insider Transaction Report

Form 4/AAmended
Period: 2009-11-02
MEADE HARRY
SVP, Transgenic Research
Transactions
  • Award

    Common Stock

    2009-11-02$1.21/sh+15,403$18,63831,257 total
  • Tax Payment

    Common Stock

    2009-11-02$1.21/sh5,520$6,67925,737 total
Holdings
  • Common Stock

    (indirect: By 401(k))
    5,302
Footnotes (2)
  • [F1]Reflects total bonus shares issuable, before forfeitures for tax withholding. The number of shares in the original Form 4 showed bonus shares issued, net of a number of shares forfeited for taxes.
  • [F2]This is the correct number of shares forfeited for tax withholding. The original Form 4 did not show share forfeitures or reflect the correct number of shares forfeited.

Issuer

GTC BIOTHERAPEUTICS INC

CIK 0000904973

Entity typeother

Related Parties

1
  • filerCIK 0001241322

Filing Metadata

Form type
4/A
Filed
Nov 12, 7:00 PM ET
Accepted
Nov 13, 4:52 PM ET
Size
7.6 KB